Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(8%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_4
1
8%
Ph not_applicable
2
17%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(7)
Terminated(2)
Other(2)

Detailed Status

Completed7
unknown2
Recruiting1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

completed758%
recruiting18%
terminated18%
withdrawn18%
unknown217%

Recent Activity

1 active trials
Showing 5 of 12
recruiting

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

NCT05964504
withdrawn

Panc CA Risk Model & Biomarker Testing In High-Risk Cohort

NCT05287347
completedphase_4

Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis

NCT03445845
unknown

'Lung Health Check' Biomarker Study

NCT04957433
terminated

Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis

NCT02474888
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT05964504

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

Recruiting
NCT05287347

Panc CA Risk Model & Biomarker Testing In High-Risk Cohort

Withdrawn
NCT03445845Phase 4

Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis

Completed
NCT04957433

'Lung Health Check' Biomarker Study

Unknown
NCT02474888

Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis

Terminated
NCT00503893

Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies

Unknown
NCT01970930

Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients

Completed
NCT02524041Not Applicable

Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary Hyperparathyroidism

Completed
NCT02540187

Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients

Completed
NCT02502552

Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort

Completed
NCT02549248

Nanoparticles Analysis in Lung and Bronchi During Various Pulmonary Interstitial Diseases and Relationships With Their Aetiology

Completed
NCT02032121Not Applicable

Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors

Completed

All 12 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
12